How to apply ex-vivo split liver transplantation safely and feasibly: A three-step approach

Table 2 Clinical data comparison between split liver transplantation and whole liver transplantation cases

	Split liver transplantation (n = 25)	Whole liver transplantation (n = 81)	P value
Gender (male/female)	17/8	65/16	0.273
Age (yr)	1.83 (0.55, 43.00)	49 (40.50, 55.00)	0.001
Underlying diseases
Decompensated cirrhosis	5	48	0.001
Liver cancer	2	15	0.210
One-week postoperative indicators
TB	26.400 (12.950, 34.350)	28.250 (17.525, 48.925)	0.274
ALT	176.0 (81.5, 259.5)	73.5 (43.5, 115.5)	0.000
AST	42.00 (32.00, 79.00)	29.00 (20.25, 49.25)	0.004
GGT	139.0 (102.5, 227.5)	118.0 (64.0, 174.0)	0.117
Two-week postoperative indicators
TB	11.80 (7.95, 20.55)	20.80 (15.20, 26.30)	0.003
ALT	63.0 (29.5, 82.5)	40.0 (21.0, 82.0)	0.154
AST	41.5 (20.5, 61.5)	26.0 (17.0, 41.0)	0.014
GGT	81.0 (54.5, 182.5)	114 (56.0, 201.0)	0.528
Postoperative complications			0.584
Intra-abdominal bleeding	0	5
Hepatic artery thrombosis	1	3
Pulmonary infections	3	8
Abdominal infection	0	1
Bile leakage	0	0
Intestinal leakage	0	0
30-d postoperative mortality	0	1

TB: Total bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase.